JP2006501155A5 - - Google Patents

Download PDF

Info

Publication number
JP2006501155A5
JP2006501155A5 JP2004508800A JP2004508800A JP2006501155A5 JP 2006501155 A5 JP2006501155 A5 JP 2006501155A5 JP 2004508800 A JP2004508800 A JP 2004508800A JP 2004508800 A JP2004508800 A JP 2004508800A JP 2006501155 A5 JP2006501155 A5 JP 2006501155A5
Authority
JP
Japan
Prior art keywords
hydroxy
formamide
hydrazinocarbonyl
heptyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004508800A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006501155A (ja
JP4563798B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/017054 external-priority patent/WO2003101442A1/en
Publication of JP2006501155A publication Critical patent/JP2006501155A/ja
Publication of JP2006501155A5 publication Critical patent/JP2006501155A5/ja
Application granted granted Critical
Publication of JP4563798B2 publication Critical patent/JP4563798B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004508800A 2002-05-31 2003-05-30 ペプチドデホルミラーゼ阻害剤 Expired - Fee Related JP4563798B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38445702P 2002-05-31 2002-05-31
PCT/US2003/017054 WO2003101442A1 (en) 2002-05-31 2003-05-30 Peptide deformylase inhibitors

Publications (3)

Publication Number Publication Date
JP2006501155A JP2006501155A (ja) 2006-01-12
JP2006501155A5 true JP2006501155A5 (https=) 2010-02-12
JP4563798B2 JP4563798B2 (ja) 2010-10-13

Family

ID=29712035

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004508800A Expired - Fee Related JP4563798B2 (ja) 2002-05-31 2003-05-30 ペプチドデホルミラーゼ阻害剤

Country Status (25)

Country Link
US (1) US7919528B2 (https=)
EP (1) EP1509218A4 (https=)
JP (1) JP4563798B2 (https=)
KR (2) KR20100121553A (https=)
AP (1) AP1795A (https=)
AR (1) AR039916A1 (https=)
AU (1) AU2003247445C1 (https=)
BR (1) BRPI0311318B1 (https=)
CA (1) CA2487805C (https=)
EA (1) EA007786B1 (https=)
EC (1) ECSP045466A (https=)
IL (1) IL164973A (https=)
IS (1) IS7610A (https=)
MX (1) MXPA04011951A (https=)
MY (1) MY133625A (https=)
NO (1) NO335263B1 (https=)
NZ (1) NZ536103A (https=)
OA (1) OA12823A (https=)
PE (1) PE20040528A1 (https=)
PL (1) PL213139B1 (https=)
TW (1) TWI304059B (https=)
UA (1) UA78563C2 (https=)
UY (1) UY27813A1 (https=)
WO (1) WO2003101442A1 (https=)
ZA (1) ZA200408315B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0229673D0 (en) * 2002-12-19 2003-01-29 British Biotech Pharm Antibacterial agents
US7332485B2 (en) * 2003-07-08 2008-02-19 Smithkline Beecham Corp Peptide deformylase inhibitors
US7507726B2 (en) * 2003-08-15 2009-03-24 Smithklinebeecham Corporation Peptide deformylase inhibitors
PE20060718A1 (es) * 2004-09-07 2006-10-04 Glaxo Group Ltd Compuestos 2-ciano pirimidinas sustitituidas como inhibidores de cisteina proteasas
WO2006055663A2 (en) 2004-11-17 2006-05-26 Smithkline Beecham Corporation The use of novel antibacterial compounds
DE102005019181A1 (de) * 2005-04-25 2006-10-26 Novartis Ag Peptid-Deformylase (PDF) Inhibitoren 1
BRPI0610842A2 (pt) * 2005-04-25 2010-07-27 Novartis Ag derivados de imidazo(1,2-a) piridina úteis como inibidores de peptìdeo desformilase (pdf)
WO2007067904A2 (en) * 2005-12-06 2007-06-14 Smithkline Beecham Corporation Peptide deformylase inhibitors
WO2007067906A2 (en) * 2005-12-09 2007-06-14 Smithkline Beecham Corporation Peptide deformylase inhibitors
EP1918284A1 (en) * 2006-10-30 2008-05-07 Glaxo Group Hydrazinopyrimidines as cysteine protease inhibitors
EP2028182A1 (en) * 2007-08-21 2009-02-25 Glaxo Group Limited Cysteine protease inhibitors
UA108596C2 (xx) * 2007-11-09 2015-05-25 Інгібітори пептиддеформілази
DE102010044131A1 (de) * 2010-11-18 2012-05-24 Bayer Schering Pharma Aktiengesellschaft Substituiertes Natrium-1H-pyrazol-5-olat
JP5959537B2 (ja) 2011-01-28 2016-08-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換ピリジニル−ピリミジン及び医薬としてのその使用
TW201249824A (en) 2011-03-09 2012-12-16 Glaxosmithkline Llc Peptide deformylase inhibitors
PL2847183T3 (pl) * 2012-05-08 2017-11-30 Bayer Pharma Aktiengesellschaft Sposób wytwarzania związków triazolowych
WO2014141181A1 (en) 2013-03-15 2014-09-18 Glaxosmithkline Intellectual Property No 2 Limited Process for preparing peptide deformylase inhibitors
CN110452224B (zh) * 2019-08-30 2022-06-03 西南大学 嘧啶唑醇类化合物及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9223904D0 (en) 1992-11-13 1993-01-06 British Bio Technology Inhibition of cytokine production
US6013792A (en) 1993-08-05 2000-01-11 Syntex (U.S.A.), Inc. Matrix metalloprotease inhibitors
US6037472A (en) 1993-11-04 2000-03-14 Syntex (U.S.A.) Inc. Matrix metalloprotease inhibitors
US6028110A (en) 1994-05-28 2000-02-22 British Biotech Pharmaceuticals Ltd. Succinyl hydroxamic acid, N-formyl-N-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors
US6235787B1 (en) * 1997-06-30 2001-05-22 Hoffmann-La Roche Inc. Hydrazine derivatives
DK1052984T3 (da) * 1998-02-07 2004-09-20 Vernalis Oxford Ltd Antibakterielle midler
US6239151B1 (en) * 1998-06-26 2001-05-29 Hoffmann-La Roche Inc. Compounds as inhibitor of tumor necrosis factor alpha release
GB9827805D0 (en) 1998-12-16 1999-02-10 British Biotech Pharm Antibacterial agents
WO2000042026A1 (en) 1999-01-15 2000-07-20 Novo Nordisk A/S Non-peptide glp-1 agonists
EP1169031A1 (en) * 1999-04-09 2002-01-09 British Biotech Pharmaceuticals Limited Antimicrobial agents
MXPA02001394A (es) * 1999-08-10 2002-08-12 British Biotech Pharm Agentes antibacterianos.
DE69924887T2 (de) * 1999-08-10 2006-03-09 Vernalis (Oxford) Ltd., Abington Antibakterielle mittel
AR028075A1 (es) * 2000-05-05 2003-04-23 Smithkline Beecham Corp Inhibidores de la peptido-desformilasa
DE10040783A1 (de) 2000-08-21 2002-03-07 Merck Patent Gmbh AZA-Aminosäurederivate (Faktor X¶a¶-Inhibitoren 15)
ATE298565T1 (de) * 2000-11-23 2005-07-15 Vernalis Oxford Ltd N-formyl hydroxylamine derivate als inhibitoren der bakteriellen polypeptid deformylase zur behandlung von mikrobiellen infektionen
AR032920A1 (es) 2001-03-01 2003-12-03 Smithkline Beecham Corp Compuestos inhibidores de las peptido-deformilasas y medios para tratar infecciones bacterianas utilizando dichos inhibidores
US7442793B2 (en) 2002-12-11 2008-10-28 Smithkline Beecham Corporation Peptide deformylase inhibitors
US7332485B2 (en) 2003-07-08 2008-02-19 Smithkline Beecham Corp Peptide deformylase inhibitors
US7507726B2 (en) 2003-08-15 2009-03-24 Smithklinebeecham Corporation Peptide deformylase inhibitors
WO2006055663A2 (en) 2004-11-17 2006-05-26 Smithkline Beecham Corporation The use of novel antibacterial compounds
UA108596C2 (xx) 2007-11-09 2015-05-25 Інгібітори пептиддеформілази

Similar Documents

Publication Publication Date Title
JP2006501155A5 (https=)
DE69531457T2 (de) Sulfonamide
AU2010214095B2 (en) Novel amino azaheterocyclic carboxamides
CA2487805A1 (en) Peptide deformylase inhibitors
AU2005304393B2 (en) IL-12 modulatory compounds
JP6635949B2 (ja) 炎症性および自己免疫性の病気の処置のためのmth1阻害剤
US8785445B2 (en) 7-phenoxychroman carboxylic acid derivatives
HUP0400691A2 (hu) Pirimidinamin-származékok és ezeket tartalmazó gyógyászati készítmények, mint angiogenézis modulátorok
JP2008519850A5 (https=)
JP2012518037A (ja) mTORキナーゼ阻害剤としてのインドール/ベンゾイミダゾール化合物
CZ20023199A3 (cs) Modulátory receptoru adenosinu
OA11856A (en) Aminopyrimidines as sorbitol dehydrogenase inhibitors.
JP2016504289A (ja) がん治療用のピリミジン−2,4−ジアミン誘導体
EP2257541A1 (en) Modulators for amyloid beta
JP2013545741A (ja) Lrrk2調節薬としてのピラゾールアミノピリミジン誘導体
CZ349197A3 (cs) Alfa-substituované pyrimidin-thioalkylové a alkylethérové sloučeniny
TW394763B (en) Sulfonamide compounds having inhibitory activity on endothelin receptors, their preparation process and pharmacentical compositions containing same
JP2001064262A (ja) ピラゾール類
JPH08510462A (ja) 除草性の化合物
JP2000063377A (ja) 置換ピリジンの製造方法
CA2959194A1 (en) 4-substituted-2-(n-(5-substituted allyl amide)phenyl)amino)pyrimidine compound, its use as an egfr inhibitor, and preparation and application thereof
JPS6042380A (ja) ジヒドロピリジン抗虚血および降圧薬